Zhengye Biotechnology Holding (ZYBT) Short-term Investments (2023 - 2025)
Zhengye Biotechnology Holding has reported Short-term Investments over the past 3 years, most recently at $208669.0 for Q4 2025.
- Quarterly Short-term Investments rose 4.6% to $208669.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $208669.0 through Dec 2025, up 4.6% year-over-year, with the annual reading at $11000.0 for FY2025, 88.89% down from the prior year.
- Short-term Investments was $208669.0 for Q4 2025 at Zhengye Biotechnology Holding, down from $282000.0 in the prior quarter.
- Over five years, Short-term Investments peaked at $282000.0 in Q2 2025 and troughed at $169998.2 in Q4 2023.
- The 3-year median for Short-term Investments is $204082.6 (2024), against an average of $215040.8.
- Year-over-year, Short-term Investments grew 17.35% in 2024 and then rose 4.6% in 2025.
- A 3-year view of Short-term Investments shows it stood at $169998.2 in 2023, then increased by 17.35% to $199496.1 in 2024, then grew by 4.6% to $208669.0 in 2025.
- Per Business Quant, the three most recent readings for ZYBT's Short-term Investments are $208669.0 (Q4 2025), $282000.0 (Q2 2025), and $199496.1 (Q4 2024).